Wiley launches its first Spectral Analysis API portfolio, giving labs a faster path from unknown substance to validated answer
Business Announcement
Updates every hour. Last Updated: 24-Oct-2026 22:16 ET (25-Oct-2026 02:16 GMT/UTC)
Researchers at The University of Texas at Arlington have received more than $4.6 million in federal funding to study how harmful bacteria become resistant to antibiotics and how they interact with the body during infection. By understanding how bacteria adapt under stress, the findings could lead to improved treatments and better protection against dangerous infections.
To what extent does the allocation of aid for combating disease correspond to disease burden? LMU researchers have developed a machine learning pipeline that helps uncover relative discrepancies in aid distribution.
The International Osteoporosis Foundation (IOF) is pleased to announce the appointment of Professor René Rizzoli as the next Editor-in-Chief for the European Office of Osteoporosis International and Archives of Osteoporosis, effective 1 September 2026.
Professor René Rizzoli, MD, is an internist and endocrinologist with subspecialty expertise in metabolic bone diseases, osteoporosis, and disorders of mineral metabolism. He is Emeritus Professor of Medicine at the University Hospitals of Geneva, former Head of the Service of Bone Diseases and former Chair of the Department of Rehabilitation and Geriatrics. Professor Rizzoli previously served as Chair of the IOF Committee of Scientific Advisors and currently chairs the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Biotech company Matricelf and Loewenstein Rehabilitation Medical Center will collaborate in preparations for the world’s first implantation of an engineered spinal cord in a paralyzed patient. The scientific breakthrough is based on a revolutionary organ-engineering technology developed at TAU by Prof. Tal Dvir of the Sagol Center for Regenerative Biotechnology
Brands that market hemp-derived, intoxicating cannabinoid products are capitalizing on lack of oversight on social media platforms to reach consumers, according to Rutgers Health researchers.
Brands selling intoxicating hemp products such as Delta-8 THC are using memes, cartoons and pop-culture references to market on Instagram while rarely warning about health risks or age limits, according to a new study in the journal Addiction. Nearly half of posts included youth-oriented content. Recreational marketing was widespread. Safety information was rare. Appeals varied by product type. Use of intoxicating hemp products has grown in the United States in recent years, alongside reported poisonings, emergency department visits and psychotic episodes. The study authors note that largely underregulated social media marketing may be contributing to that growth. The findings come at a pivotal moment for federal policy.